{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:38:21Z","timestamp":1791405501318,"version":"4.3.3"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301869\/2017-0"],"award-info":[{"award-number":["301869\/2017-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["442522\/2019-3"],"award-info":[{"award-number":["442522\/2019-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The absence of nursing care plans aimed at people living with HTLV-1 (PLHTLV) led us to develop and test a proposed nursing care plan based on the evaluation of 55 PLHTLV to outline interventions according to the clinical stage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>After interviews with symptomatic patients, nursing diagnoses were made using the NANDA International Nursing Diagnoses (The International Nursing Knowledge Association). Subsequently, interventions were selected through the Classification of Nursing Interventions (NIC), and expected results were selected through the Classification of Nursing Outcomes (NOC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The actual diagnoses included (ii) chronic pain, (iii) impaired urinary elimination, and (iv) sexual dysfunction; the health promotion diagnosis was (i) risk-prone health behavior; and the risk diagnoses were (i) risk of feeling powerless and (ii) risk of falls in adults. Nursing care must prevent the lack of adherence to monitoring, establish goals and promote family involvement. A safe home environment requires intervention for fall prevention. Full support in understanding pharmacological and non-pharmacological therapies for chronic pain is needed. Interventions allow patients with impaired urinary function to be reintroduced to society. For sexual dysfunction, it is necessary to discuss safe sex and behavioral changes. Regarding risk behaviors, it is necessary to guide the patient\/family, adapt language to the education level of these individuals, and help them better accept the condition, among other guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The development of a nursing care plan for PLHTLV is essential for preventing the rapid progression of disease and the improvement of the quality of life of PLHTLV and should be included in the multidisciplinary approach to the secondary level of prevention of HTLV-1.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.854970","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T10:14:29Z","timestamp":1650881669000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Providing a Nursing Care Plan as a Requirement for Secondary Prevention for People Living With HTLV-1"],"prefix":"10.3389","volume":"9","author":[{"given":"Cintia Yolette Urbano Pauxis","family":"Aben-Athar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilson Coelho","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Silva","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlos Ros\u00e1rio","family":"Vallinoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaura Maria Vieira","family":"Cayres Vallinoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human t-lymphotropic virus type-1 in patients with tropical spastic paraparesis","volume":"8452","author":"Gessain","year":"1985","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy: a new clinical entity","volume":"327","author":"Osame","year":"1986","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.24875\/AIDSRev.19000108","article-title":"HTLV-1 associated neurological complex. What is hidden below the water?","volume":"21","author":"Araujo","year":"2019","journal-title":"AIDS Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13023-021-01990-3","article-title":"Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy\/tropical spastic paraparesis: a nationwide registry study in Japan","volume":"16","author":"Iijima","year":"2021","journal-title":"Orphanet J Rare Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/S0140-6736(18)30974-7","article-title":"Time to eradicate HTLV-1: an open letter to WHO","volume":"391","author":"Martin","year":"2018","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v10010001","article-title":"HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment","volume":"10","author":"Futsch","year":"2018","journal-title":"Viruses."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0008761","DOI":"10.1371\/journal.pntd.0008761","article-title":"Health state utility values in people living with htlv-1 and in patients with HAM\/TSP: The impact of a neglected disease on the quality of life","volume":"14","author":"Rosadas","year":"2020","journal-title":"PLoS Negl Trop Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s13365-020-00905-5","article-title":"Cognitive impairment in the HTLV-1 infection: a comparative study associated with functional performance","volume":"27","author":"de Paula","year":"2021","journal-title":"J Neurovirol"},{"key":"B10","unstructured":"GenevaHuman T-Lymphotropic Virus Type 1: Technical Report2021"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2020605","DOI":"10.1590\/0037-8682-605-2020","article-title":"Brazilian protocol for sexually transmitted infections 2020: human T-cell lymphotropic virus (HTLV) infection","volume":"54","author":"Rosadas","year":"2021","journal-title":"Rev Soc Bras Med Trop."},{"key":"B12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.14295\/jmphc.v5i2.210","article-title":"Sistematiza\u00e7\u00e3o da assist\u00eancia de enfermagem: o contexto hist\u00f3rico, o processo e obst\u00e1culos da implanta\u00e7\u00e3o","volume":"5","author":"Dos Santos","year":"2014","journal-title":"J Manag Prim Health Care."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e00005419","DOI":"10.1590\/0102-311x00005419","article-title":"HTLV: uma infec\u00e7\u00e3o estigmatizante?","volume":"35","author":"Garcia","year":"2019","journal-title":"Cad Sa\u00fade P\u00fablica."},{"key":"B14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.33233\/eb.v17i2.1009","article-title":"Conhecimento da enfermeira do Programa de Sa\u00fade da Fam\u00edlia sobre o v\u00edrus linfotr\u00f3pico de c\u00e9lulas T humanas","volume":"17","author":"Soares","year":"2018","journal-title":"Enferm Brasil."},{"key":"B15","doi-asserted-by":"publisher","first-page":"37991","DOI":"10.18471\/rbe.v34.37991","article-title":"Diagn\u00f3sticos de Enfermagem em pessoas soropositivas pelo v\u00edrus linfotr\u00f3pico T humano","volume":"34","author":"Souza","year":"2020","journal-title":"Rev Baiana Enferm."},{"key":"B16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bjid.2020.08.009","article-title":"Limitations in daily activities, risk awareness, social participation, and pain in patients with HTLV-1 using the SALSA and participation scales","volume":"24","author":"Aben-Athar","year":"2020","journal-title":"Braz J Infect Dis."},{"key":"B17","volume-title":"Diagn\u00f3sticos de Enfermagem da NANDA-I: Defini\u00e7\u00f5es e Classifica\u00e7\u00e3o","author":"Herdman","year":"2021"},{"key":"B18","volume-title":"Classifica\u00e7\u00e3o dos resultados de enfermagem (NOC)","author":"Moorhead","year":"2010"},{"key":"B19","volume-title":"Classifica\u00e7\u00e3o das interven\u00e7\u00f5es de enfermagem (NIC)","author":"Bulechek","year":"2010"},{"key":"B20","first-page":"437","article-title":"A import\u00e2ncia da realiza\u00e7\u00e3o de um atendimento integrado e multidisciplinar \u00e0s pessoas vivendo com HTLV","volume-title":"Cadernos Hemominas","author":"Galv\u00e3o-Castro","year":"2016"},{"key":"B21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7748\/ns.30.26.51.s48","article-title":"Developing nursing care plans","volume":"30","author":"Ballantyne","year":"2016","journal-title":"Nurs Stand."},{"key":"B22","volume-title":"NANDA Diagn\u00f3sticos de enfermagem da NANDA-I: defini\u00e7\u00f5es e classifica\u00e7\u00e3o 2018-2020 [recurso eletr\u00f4nico] \/ [NANDA International]. tradu\u00e7\u00e3o: Regina Machado Garcez; revis\u00e3o t\u00e9cnica: Alba Lucia Bottura Leite de Barros [ et al.]","year":"2018"},{"key":"B23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1590\/1414-462x201700010186","article-title":"(Des)conhecimento, adoecimento e limita\u00e7\u00f5es impostas pelo HTLV: experi\u00eancias de mulheres soropositivas","volume":"25","author":"Dos Santos","year":"2017","journal-title":"Cad. Sa\u00fade Colet"},{"key":"B24","first-page":"304","article-title":"Aspectos da reabilita\u00e7\u00e3o no paciente com mielopatia associada ao HTLV-1","author":"Nepomuceno","year":"2016"},{"key":"B25","doi-asserted-by":"publisher","first-page":"03327","DOI":"10.1590\/s1980-220x2017025503327","article-title":"A\u00e7\u00f5es e intera\u00e7\u00f5es na pr\u00e1tica cl\u00ednica do enfermeiro na Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade","volume":"52","author":"Kahl","year":"2018","journal-title":"Rev Esc Enferm USP."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e003303","DOI":"10.1590\/1980-5918.033.ao03","article-title":"Center of gravity oscillations in HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"33","author":"Lago","year":"2020","journal-title":"Fisioterapia em Movimento"},{"key":"B27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bjid.2016.05.010","article-title":"Quality of life and pain multidimensional aspects in individuals with HTLV-1","volume":"20","author":"Mac\u00eado","year":"2016","journal-title":"Braz J Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1590\/S0004-282X2012005000006","article-title":"Quality of life in patients with HTL V-I associated myelopathy\/tropical spastic paraparesis","volume":"70","author":"Martins","year":"2012","journal-title":"Arq Neuropsiquiatr."},{"key":"B29","volume-title":"Representa\u00e7\u00f5es sociais sobre a viv\u00eancia da sexualidade em homens e mulheres soropositivas para o HTLV","author":"Rivemales","year":"2013"},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/civ229","article-title":"Neurological manifestations in HTLV-1 infected individuals without HAM\/TSP: a longitudinal cohort study","volume":"61","author":"Tanajura","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4025\/cienccuidsaude.v11i3.20262","article-title":"Facilidades e dificuldades encontradas na realiza\u00e7\u00e3o do aconselhamento \u00e0s pessoas que vivem com HTLV","volume":"11","author":"Santos","year":"2012","journal-title":"Ci\u00eanc Cuid Sa\u00fade."},{"key":"B32","first-page":"460","article-title":"Aconselhamento dos indiv\u00edduos positivos e preven\u00e7\u00e3o da infec\u00e7\u00e3o por HTLV","volume-title":"Cadernos Hemominas","author":"Caneiro-Poietti","year":"2016"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.854970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T10:14:35Z","timestamp":1650881675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.854970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":32,"alternative-id":["10.3389\/fmed.2022.854970"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.854970","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"article-number":"854970"}}